2009
DOI: 10.2174/157016309789869047
|View full text |Cite
|
Sign up to set email alerts
|

Mouse Models of Autoimmune Diseases

Abstract: Significant progress has been made in past decades in our understanding of the basic mechanisms underlying autoimmune diseases. Nevertheless, many questions remain unanswered, in particular regarding the mechanisms at very early stages of these diseases. Reliable animal models are of crucial importance in basic research and may help us to understand central disease pathways. They are also indispensable for pre-clinical drug testing. Here we present and discuss two mouse models of rheumatoid arthritis and multi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 102 publications
0
2
0
Order By: Relevance
“…Preclinical efficacy of antibody therapeutics for oncology is commonly demonstrated using xenograft models in immuno-deficient mice, because these are less likely to elicit immune responses against either the xenograft or therapeutic antibody 1, 2 . However, to investigate increasingly more complex therapeutic concepts that go beyond targeting of the tumor or disease-tissue directly, the presence of relevant cross-talk between the intact immune system, disease associated immune cells, and disease tissue microenvironment are essential.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Preclinical efficacy of antibody therapeutics for oncology is commonly demonstrated using xenograft models in immuno-deficient mice, because these are less likely to elicit immune responses against either the xenograft or therapeutic antibody 1, 2 . However, to investigate increasingly more complex therapeutic concepts that go beyond targeting of the tumor or disease-tissue directly, the presence of relevant cross-talk between the intact immune system, disease associated immune cells, and disease tissue microenvironment are essential.…”
Section: Introductionmentioning
confidence: 99%
“…However, to investigate increasingly more complex therapeutic concepts that go beyond targeting of the tumor or disease-tissue directly, the presence of relevant cross-talk between the intact immune system, disease associated immune cells, and disease tissue microenvironment are essential. As a consequence, the efficacy and safety of these complex concepts are often studied using syngeneic models in immuno-competent mice employing (surrogate) mouse antibodies to maximize the use of effector functions and avoid anti-drug responses 25 .…”
Section: Introductionmentioning
confidence: 99%